Discovery of the hepatic canalicular and intestinal cholesterol transporters. New targets for treatment of hypercholesterolemia

European Review for Medical and Pharmacological Sciences

Volumn 7, Issue 2, 2003, Pages 33-39

  Zanlungo, S ^a   Nervi, F ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

ABC transporter family; ABCG5 gene; ABCGB gene; Arteriosclerosis; Cholesterol cholelithiasis

Indexed keywords

ABC TRANSPORTER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STEROL;

ANIMAL EXPERIMENT; ARTERIOSCLEROSIS; ARTERY WALL; ATHEROSCLEROTIC PLAQUE; CHOLELITHIASIS; CHOLESTEROL BILE LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CRYSTALLIZATION; DNA POLYMORPHISM; GALLBLADDER EMPTYING; GALLSTONE FORMATION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ENGINEERING; HYPERCHOLESTEROLEMIA; INTESTINE CELL; INTESTINE SECRETION; LIPOPROTEIN BLOOD LEVEL; LIVER CELL MEMBRANE; MOUSE; NONHUMAN; REVIEW;

ANIMALS; ANTILIPEMIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BILE CANALICULI; CHOLESTEROL; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINES; MICE;

EID: 0042309695     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Murray JL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269-1276.
2. Lee SP, Ko CW. Gallstones. In: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW, eds. Textbook of Gastroenterology. 3rd Edition. Philadelphia: Lippincott Williams & Wilkins, 1999; 2258-2280.
3. Miquel JF, Covarrubias C, Villarroel L, Mingrone G, Greco AV, Carvallo P, Marshall G, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics and Maoris. Gastroenterology 1998; 115: 937-946.
4. Lazcano-Ponce E, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba I, Alonso P, Urista GA, Nervi F. Epidemiology and molecular pathology of gallbladder cancer: a review. CA Cancer J Clin 2001; 51: 349-364.
5. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
6. Reaven GM. Insulin resistance: a chicken that has come to roost. Ann N Y Acad Sci 1999; 892:45-57.
7. Grundy SM, Abate N, Chandalia M. Diet composition and the metabolic syndrome: what is the optimal fat intake? Am J Med 2002; 13 (Suppl 9)B: 25-29.
8. Goldstein JL, Brown MS. Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis. Circulation 1987; 76: 504-507.
9. Scott R. Lipid modifying agents: mechanisms of action and reduction of cardiovascular disease. Clin Exp Pharmacol Physiol 1997; 24: A26-28.
10. Trigatti B, Rigotti A, Krieger M. The role of the high-density lipoprotein receptor SR-B1 in cholesterol metabolism. Curr Opin Lipidol 2000; 123-131.
11. Braun A, Trigatti BL, Post MJ, et al. Loss of SR-B1 expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002; 90: 270-276.
12. Kozarsky KF, Donahee MH, Glick JM, Krieger M, Rader DJ. Gene transfer and hepatic overexpression of the HDL receptor SR-B1 reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000; 20: 721-727.
13. Acton SL, Kozarsky KF, Rigotti A. The HDL receptor SR-B1: a new therapeutic target for atherosclerosis? Mol Med Today. 1999; 5: 518-524.
14. Rigotti A, Krieger M. Getting a handle on "good" cholesterol with the high-density lipoprotein receptor. N Engl J Med 1999 Dec 23; 341 (26): 2011-2013.
15. Amigo L, Zanlungo S, Mendoza H, Miquel JF, Nervi F. Risk factors and pathogenesis of cholesterol gallstones: state of the art. Eur Rev Med Pharmacol Sci 1999; 3: 241-246.
16. Paumgartner G, Sauerbruch T. Gallstones: pathogenesis. Lancet 1991; 338: 1117-1121.
17. Puglielli L, Rigotti A, Nervi A. La litiasi biliare. In G. Gasbarrini and A.V. Greco, eds. Trattato di Gastroenterologia. Edizioni Minerva Medica, Torino Italia. 2001. Pag 689-703.
18. Dowling RH. Review: pathogenesis of gallstones. Alim Pharmacol Therapeutics 2000; 14(S2): 39-47.
19. Zanlungo S, Amigo L, Mendoza H, Miquel JF, Vío C, Glick JM, Rodriguez A, Quiñones V, Rigotti A, Nervi F. Sterol carrier protein 2 gene transfer changes lipid metabolism and Enterohepatic sterol circulation in mice. Gastroenterology 2000; 119: 1708-1719.
20. Amigo L, Zanlungo S, Miquel JF, et al. Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion. J Lipid Res 2003; 44: 399-340.
21. Amigo L, Mendoza H, Castro J, et al. Relevance of Niemann-Pick type C1 protein expression in controlling plasma cholesterol and biliary lipid secretion in mice. Hepatology 2002; 36: 819-828.
22. Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, Van Deemter L, Mol CA, Homozygous disruption of the murine Mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75: 451-462.
23. Wang R, Salem M, Yousef IM, Tuchweber B, Lam P, Childs SJ, Helgason CD. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in non progressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci USA 2001; 98: 2011-2016.
24. Rigotti A, Marzolo MP, Nervi F. Lipid transport from the hepatocyte into the bile. In: Kleinzeller A, Fambrough DM, eds. Current Topics in Membranes. Cell Lipids Hoekstra D, guest ed. San Diego: Academic Press, Inc. 1994; 40: 579-615.
25. Lu TT, Repa JJ, Mangelsdorf DJ. Orphan Nuclear Receptors as eLiXiRs and FiXeRs of sterol metabolism. J. Biol Chem 2001; 276: 37735-377388.
26. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 1866-1870.
27. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290: 1771-1775.
28. Lee MH, Lu K, Hazards S, Yu H, Shulenin S, Hidaka H, Kojima H. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001; 27: 79-83.
29. Björkhem I, Boberg K, Leitersdorf E. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The metabolic and molecular bases of inherited disease. Volume II. New York: McGraw-Hill 1995; 2961-2988.
30. Yu L, Li-Hawkins J, Hammer RE, Berge E, Horton JD, Cohen JC, Hobbs HH. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002; 110: 671-680.
31. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. Disruption of ABCG5 and ABCG8 in mice reveals their crucial role in biliary cholesterol secretion Proc Natl Acad Sci USA 2002; 99: 16237-16242.
32. Repa J, Berge K, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ. Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors α and β. J Biol Chem 2002; 277, 18793-18800.
33. Steiner HH, Andresen SM, Gustafsson JA, Nebb HI. Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J Biol Chem 2002; 277: 10691-10697.